Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial - Koch, T; Dahlke, C; Fathi, A (Lancet Infect Dis, 2020)
. doi:10.1016/S1473-3099(20)30248-6